Sanara MedTech Statistics

Total Valuation

Sanara MedTech has a market cap or net worth of $252.50 million. The enterprise value is $276.54 million.

Market Cap	252.50M
Enterprise Value	276.54M

Important Dates

The next estimated earnings date is Monday, August 11, 2025, before market open.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Sanara MedTech has 8.89 million shares outstanding. The number of shares has increased by 2.18% in one year.

Current Share Class	8.89M
Shares Outstanding	8.89M
Shares Change (YoY)	+2.18%
Shares Change (QoQ)	+0.45%
Owned by Insiders (%)	30.90%
Owned by Institutions (%)	17.29%
Float	3.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.57
Forward PS	n/a
PB Ratio	6.71
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.02
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.77, with a Debt / Equity ratio of 1.22.

Current Ratio	2.77
Quick Ratio	2.45
Debt / Equity	1.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.51

Financial Efficiency

Return on equity (ROE) is -29.22% and return on invested capital (ROIC) is -5.80%.

Return on Equity (ROE)	-29.22%
Return on Assets (ROA)	-4.72%
Return on Invested Capital (ROIC)	-5.80%
Return on Capital Employed (ROCE)	-7.60%
Revenue Per Employee	$649,432
Profits Per Employee	-$81,046
Employee Count	141
Asset Turnover	1.09
Inventory Turnover	2.19

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.43% in the last 52 weeks. The beta is 1.33, so Sanara MedTech's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	+1.43%
50-Day Moving Average	30.24
200-Day Moving Average	32.58
Relative Strength Index (RSI)	44.50
Average Volume (20 Days)	41,041

Short Selling Information

The latest short interest is 208,786, so 2.35% of the outstanding shares have been sold short.

Short Interest	208,786
Short Previous Month	183,747
Short % of Shares Out	2.35%
Short % of Float	5.81%
Short Ratio (days to cover)	6.29

Income Statement

In the last 12 months, Sanara MedTech had revenue of $91.57 million and -$11.43 million in losses. Loss per share was -$1.34.

Revenue	91.57M
Gross Profit	83.49M
Operating Income	-6.31M
Pretax Income	-4.89M
Net Income	-11.43M
EBITDA	-1.88M
EBIT	-6.31M
Loss Per Share	-$1.34

Full Income Statement

Balance Sheet

The company has $20.69 million in cash and $44.72 million in debt, giving a net cash position of -$24.03 million or -$2.70 per share.

Cash & Cash Equivalents	20.69M
Total Debt	44.72M
Net Cash	-24.03M
Net Cash Per Share	-$2.70
Equity (Book Value)	36.67M
Book Value Per Share	4.12
Working Capital	23.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$428,298 and capital expenditures -$1.86 million, giving a free cash flow of -$2.29 million.

Operating Cash Flow	-428,298
Capital Expenditures	-1.86M
Free Cash Flow	-2.29M
FCF Per Share	-$0.26

Full Cash Flow Statement

Margins

Gross margin is 91.17%, with operating and profit margins of -6.90% and -12.48%.

Gross Margin	91.17%
Operating Margin	-6.90%
Pretax Margin	-12.71%
Profit Margin	-12.48%
EBITDA Margin	-2.05%
EBIT Margin	-6.90%
FCF Margin	n/a

Dividends & Yields

Sanara MedTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.18%
Shareholder Yield	-2.18%
Earnings Yield	-4.53%
FCF Yield	-0.91%

Analyst Forecast

The average price target for Sanara MedTech is $49.50, which is 74.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$49.50
Price Target Difference	74.23%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 10, 2019. It was a reverse split with a ratio of 0.01:1.

Last Split Date	May 10, 2019
Split Type	Reverse
Split Ratio	0.01:1

Scores

Sanara MedTech has an Altman Z-Score of 3.28 and a Piotroski F-Score of 4.

Altman Z-Score	3.28
Piotroski F-Score	4